Article, Biophysical Assays and Fragment Screening

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

Fragment-based screening (FBS) has emerged as a powerful tool for discovering novel lead compounds, especially for challenging targets like the Adenosine A2a receptor. This stability enables the application of hit identification approaches such as fragment-based screening (FBS). References Sun D, et al.

Fragment Screening

Fragment Screening Drugs Small Molecule Biophysical Assays

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

Webinars

Stay Connected